-
MBII Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Marrone Bio Innovations (MBII)
Company Profile
Quarter (USD) | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 10.92 mm | 10.92 mm | 10.92 mm | 10.92 mm | 10.92 mm | 10.92 mm |
Cash burn (monthly) | 3.42 mm | 796.75 k | 2.54 mm | 1.77 mm | 2.80 mm | 1.11 mm |
Cash used (since last report) | 116.26 mm | 27.08 mm | 86.19 mm | 60.05 mm | 95.13 mm | 37.79 mm |
Cash remaining | -105.34 mm | -16.16 mm | -75.27 mm | -49.13 mm | -84.20 mm | -26.86 mm |
Runway (months of cash) | -30.8 | -20.3 | -29.7 | -27.8 | -30.1 | -24.2 |
13F holders | Current |
---|---|
Total holders | 2 |
Opened positions | 1 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 9.51 mm |
Total shares | 8.57 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Van Herk Investments B.V. | 8.57 mm | $9.51 mm |
Proequities | 0.00 | $0.00 |